NO892678D0 - Fremgangsmaate for fremstilling av 19-substituerte progesteronderivater. - Google Patents

Fremgangsmaate for fremstilling av 19-substituerte progesteronderivater.

Info

Publication number
NO892678D0
NO892678D0 NO892678A NO892678A NO892678D0 NO 892678 D0 NO892678 D0 NO 892678D0 NO 892678 A NO892678 A NO 892678A NO 892678 A NO892678 A NO 892678A NO 892678 D0 NO892678 D0 NO 892678D0
Authority
NO
Norway
Prior art keywords
substituted
progester
substrates
procedure
preparation
Prior art date
Application number
NO892678A
Other languages
English (en)
Other versions
NO174511B (no
NO174511C (no
NO892678L (no
Inventor
Gene Warwick Holbert
John O'neal Johnston
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO892678D0 publication Critical patent/NO892678D0/no
Publication of NO892678L publication Critical patent/NO892678L/no
Publication of NO174511B publication Critical patent/NO174511B/no
Publication of NO174511C publication Critical patent/NO174511C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO892678A 1988-06-28 1989-06-27 Analogifremgangsmaate for fremstilling av terapeutisk aktivt 21- hydroxy-10-(2-propynyl)-19-norpregn-4-en-3,20-dion NO174511B (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/212,409 US4910191A (en) 1988-06-28 1988-06-28 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors

Publications (4)

Publication Number Publication Date
NO892678D0 true NO892678D0 (no) 1989-06-27
NO892678L NO892678L (no) 1989-12-29
NO174511B NO174511B (no) 1994-02-07
NO174511C NO174511C (no) 1994-05-18

Family

ID=22790892

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892678A NO174511B (no) 1988-06-28 1989-06-27 Analogifremgangsmaate for fremstilling av terapeutisk aktivt 21- hydroxy-10-(2-propynyl)-19-norpregn-4-en-3,20-dion

Country Status (20)

Country Link
US (1) US4910191A (no)
EP (1) EP0348910B1 (no)
JP (1) JP2729320B2 (no)
KR (1) KR0160280B1 (no)
CN (1) CN1033032C (no)
AT (1) ATE122681T1 (no)
AU (1) AU610473B2 (no)
CA (1) CA1321578C (no)
DE (1) DE68922660T2 (no)
DK (1) DK167534B1 (no)
ES (1) ES2075014T3 (no)
FI (1) FI92706C (no)
HU (1) HU204066B (no)
IE (1) IE66338B1 (no)
IL (1) IL90727A (no)
NO (1) NO174511B (no)
NZ (1) NZ229696A (no)
PH (1) PH25714A (no)
PT (1) PT90988B (no)
ZA (1) ZA894754B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US7053228B2 (en) * 2000-09-18 2006-05-30 Applied Research Systems Ars Holding N.V. Sulfur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids
DE102006018888A1 (de) * 2006-04-18 2007-10-25 Bayer Schering Pharma Ag Verfahren zur Herstellung von 4-[17beta-Methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyd-(E)-oxims (Asoprisnil)
ES2393814T3 (es) 2007-04-04 2012-12-28 Sigmoid Pharma Limited Una composición farmacéutica oral
DK2471518T3 (en) 2009-05-18 2017-12-04 Sigmoid Pharma Ltd COMPOSITION INCLUDING OIL DROPS
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN102268058B (zh) * 2011-05-24 2012-10-10 湖南诺凯生物医药有限公司 制备17α-羟基孕酮或其类似物的方法
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
EP3881829A1 (en) 2014-11-07 2021-09-22 Sublimity Therapeutics Limited Compositions comprising cyclosporin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1051693A (no) * 1962-07-09
US3275621A (en) * 1963-12-18 1966-09-27 Syntex Corp 19-amino-delta4-pregnenes and-10alpha-pregnenes and process for their preparation
US3275622A (en) * 1963-12-18 1966-09-27 Syntex Corp 19-alkylidene-delta4-3, 20-keto pregnanes
US3558673A (en) * 1966-10-29 1971-01-26 Ormonoterapia Richter Spa 10beta-amino-19-nor-pregnanes and method for the preparation thereof
US3849402A (en) * 1971-01-06 1974-11-19 Steele Chem Co Ltd 19-oxygenated and 19-nor delta8(14)-steroid compounds
US4041055A (en) * 1975-11-17 1977-08-09 The Upjohn Company Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes
FR2462445A1 (fr) * 1979-07-31 1981-02-13 Roussel Uclaf Nouveaux derives 17-/(hydroxymethyl) (formamido) methylene/steroides, leur procede de preparation et leur application a l'introduction de la chaine laterale hydroxyacetyle
US4289762A (en) * 1980-06-27 1981-09-15 Merrell Dow Pharmaceuticals Inc. 10-(1,2-Propadienyl) steroids as irreversible aromatase inhibitors
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
US4293548A (en) * 1980-09-02 1981-10-06 Merrell Dow Pharmaceuticals Inc. 18-Substituted pregn-4-ene-3,20-diones
FR2498607A1 (fr) * 1981-01-29 1982-07-30 Roussel Uclaf Nouveau procede de preparation de 17a-hydroxy 17b-hydroxyacetyle steroides, produits intermediaires correspondants et produits finals obtenus
US4495102A (en) * 1982-09-03 1985-01-22 G. D. Searle & Co. Aminoalkyl steroids
US4473564A (en) * 1983-07-12 1984-09-25 Akzo N.V. 19-Thio-androstane derivatives
FR2576025B1 (fr) * 1985-01-14 1987-01-23 Roussel Uclaf Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant
GB8531745D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynyl-4-9(11)-estradiene derivatives

Also Published As

Publication number Publication date
IE66338B1 (en) 1995-12-27
CA1321578C (en) 1993-08-24
CN1033032C (zh) 1996-10-16
FI893163A0 (fi) 1989-06-28
NZ229696A (en) 1992-03-26
EP0348910A2 (en) 1990-01-03
AU610473B2 (en) 1991-05-16
DK318589D0 (da) 1989-06-27
EP0348910B1 (en) 1995-05-17
FI92706C (fi) 1994-12-27
JP2729320B2 (ja) 1998-03-18
IL90727A (en) 1993-05-13
NO174511B (no) 1994-02-07
DK167534B1 (da) 1993-11-15
ATE122681T1 (de) 1995-06-15
JPH0248598A (ja) 1990-02-19
FI92706B (fi) 1994-09-15
ES2075014T3 (es) 1995-10-01
KR910000588A (ko) 1991-01-29
KR0160280B1 (ko) 1998-11-16
NO174511C (no) 1994-05-18
HU204066B (en) 1991-11-28
PT90988A (pt) 1989-12-29
EP0348910A3 (en) 1990-03-21
CN1039593A (zh) 1990-02-14
DK318589A (da) 1989-12-29
DE68922660T2 (de) 1996-01-18
HUT51288A (en) 1990-04-28
IE892086L (en) 1989-12-28
FI893163A (fi) 1989-12-29
PH25714A (en) 1991-09-18
ZA894754B (en) 1990-05-30
DE68922660D1 (de) 1995-06-22
US4910191A (en) 1990-03-20
AU3712789A (en) 1990-01-04
IL90727A0 (en) 1990-01-18
NO892678L (no) 1989-12-29
PT90988B (pt) 1994-11-30

Similar Documents

Publication Publication Date Title
IE840302L (en) 3-(5-aminopentyl)amino-1-benzazepin-2-one-1-alkanoic acids.
NO861481L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive heterocykliske amid-derivater.
NO169900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (ih-azol-1-ylmetyl)substituerte benzotriazolderivater
NO911600D0 (no) Fremgangsmaate for fremstilling av n-(3-fluor-2-fosfonyl-metoksypropyl)-derivater av heterocykliske purin- og pyrimidinbaser.
EP0244803A3 (en) Novel dopamine beta hydroxylase inhibitors
NO892678L (no) Fremgangsmaate for fremstilling av 19-substituerte progesteronderivater.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
NO892679D0 (no) Fremgangsmaate for fremstilling av 19-fluor- eller cyano- 21-hydroxyprogesteronderivater.
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
NO163617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.
NO895233D0 (no) Fremgangsmaate for fremstilling av di- og tripeptidderivater.
NO911236L (no) Fremgangsmaate for fremstilling av haloethyl-substituerte steroidale enzyminhibitorer.
NO164651C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminofenol-derivater.
NO172119C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazol-forbindelser
NO163404C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzokinolizin-derivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2000